Josh Hardman

Josh Hardman is the founder and editor of Psychedelic Alpha, an independent media and consultancy firm devoted to the psychedelics industry—from business and drug development through to policy reform and scientific research. Using data-driven reporting, analysis and commentary, Hardman strives to empower individuals with the knowledge, network and nuance to make an impact within the emerging field of psychedelic medicine and beyond. Hardman has authored hundreds of analyses on topics broadly related to psychedelic business, policy and research, such as commercialisation, IP and regulation. He has spoken about psychedelic drug development and industry at conferences worldwide and acted as an expert witness to bodies such as the European Parliament and the Dept. of Health and Human Services.